Report cover image

Photodynamic Therapy Market (Product Type: Photosensitizer Drugs, and Devices; and Application: Cancer, Dermatological Conditions, Ophthalmology, Gastroenterology, Gynecology, Infectious Disease, and Others) - Global Industry Analysis, Size, Share, Growth

Publisher Transparency Market Research Pvt. Ltd.
Published Mar 26, 2024
Length 235 Pages
SKU # TNPR18769932

Description

Photodynamic Therapy Market (Product Type: Photosensitizer Drugs, and Devices; and Application: Cancer, Dermatological Conditions, Ophthalmology, Gastroenterology, Gynecology, Infectious Disease, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Photodynamic Therapy Market – Scope of Report

TMR’s report on the global photodynamic therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global photodynamic therapy market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global photodynamic therapy market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the photodynamic therapy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global photodynamic therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global photodynamic therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global photodynamic therapy market.

The report delves into the competitive landscape of the global photodynamic therapy market. Key players operating in the global photodynamic therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global photodynamic therapy market profiled in this report.

Key Questions Answered in Global photodynamic therapy Market Report
  • What is the sales/revenue generated by photodynamic therapy across all regions during the forecast period?
  • What are the opportunities in the global photodynamic therapy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Photodynamic Therapy Market – Research Objectives and Research Approach

The comprehensive report on the global photodynamic therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global photodynamic therapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global photodynamic therapy market.

Table of Contents

235 Pages
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Photodynamic Therapy Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Photodynamic Therapy Market Analysis and Forecasts, 2017 - 2031
5. Key Insights
5.1. Major Companies in Photodynamic Therapy
5.2. Key Industry Events
5.3. Regulatory Scenario by Region/Globally
5.4. Pipeline Analysis
5.5. Photosensitizers used in Basic Research for Cancer Treatment
6. Global Photodynamic Therapy Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2017 - 2031
6.3.1. Photosensitizer Drugs
6.3.1.1. Porphyrin Derivatives
6.3.1.1.1. Hematoporphyrin Derivative
6.3.1.1.2. Benzoporphyrin Derivative
6.3.1.1.3. Texaphyrins
6.3.1.1.4. Others
6.3.1.2. Aminolevulic acid
6.3.1.3. Chlorines
6.3.1.4. Others
6.3.2. Devices
6.3.2.1. Disposable Fiber Optic Light Delivery Devices
6.3.2.2. Diode Laser
6.3.2.3. Lamp
6.4. Market Attractiveness By Product Type
7. Global Photodynamic Therapy Market Analysis and Forecasts, By Mode of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Mode of Administration, 2017 - 2031
7.3.1. Intravenous
7.3.2. Oral
7.3.3. Topical
7.4. Market Attractiveness By Mode of Administration
8. Global Photodynamic Therapy Market Analysis and Forecasts, By Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Application, 2017 - 2031
8.3.1. Cancer
8.3.1.1. Basal Cell Carcinoma
8.3.1.2. Non-Small Cell Lung Cancer
8.3.1.3. Head & Neck Cancer
8.3.1.4. Others
8.3.2. Dermatological Conditions
8.3.2.1. Psoriasis
8.3.2.2. Acne
8.3.2.3. Actinic Keratosis
8.3.3. Ophthalmology
8.3.3.1. Age-Related Macular Degeneration
8.3.3.2. Retinal Disease
8.3.4. Gastroenterology
8.3.5. Gynecology
8.3.6. Infectious Diseases
8.3.7. Others
8.4. Market Attractiveness By Application
9. Global Photodynamic Therapy Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user , 2017 - 2031
9.3.1. Hospitals
9.3.2. Cosmetics & Dermatology Clinics
9.3.3. Cancer Treatment Centers
9.3.4. Others
9.4. Market Attractiveness By End-user
10. Global Photodynamic Therapy Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Photodynamic Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2017 - 2031
11.2.1. Photosensitizer Drugs
11.2.1.1. Porphyrin Derivatives
11.2.1.1.1. Hematoporphyrin Derivative
11.2.1.1.2. Benzoporphyrin Derivative
11.2.1.1.3. Texaphyrins
11.2.1.1.4. Others
11.2.1.2. Aminolevulic acid
11.2.1.3. Chlorines
11.2.1.4. Others
11.2.2. Devices
11.2.2.1. Disposable Fiber Optic Light Delivery Devices
11.2.2.2. Diode Laser
11.2.2.3. Lamp
11.3. Market Value Forecast By Mode of Administration, 2017 - 2031
11.3.1. Intravenous
11.3.2. Oral
11.3.3. Topical
11.4. Market Value Forecast By Application, 2017 - 2031
11.4.1. Cancer
11.4.1.1. Basal Cell Carcinoma
11.4.1.2. Non-Small Cell Lung Cancer
11.4.1.3. Head & Neck Cancer
11.4.1.4. Others
11.4.2. Dermatological Conditions
11.4.2.1. Psoriasis
11.4.2.2. Acne
11.4.2.3. Actinic Keratosis
11.4.3. Ophthalmology
11.4.3.1. Age-Related Macular Degeneration
11.4.3.2. Retinal Disease
11.4.4. Gastroenterology
11.4.5. Gynecology
11.4.6. Infectious Diseases
11.4.7. Others
11.5. Market Value Forecast By End-user, 2017 - 2031
11.5.1. Hospitals
11.5.2. Cosmetics & Dermatology Clinics
11.5.3. Cancer Treatment Centers
11.5.4. Others
11.6. Market Value Forecast By Country, 2017 - 2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Mode of Administration
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Photodynamic Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2017 - 2031
12.2.1. Photosensitizer Drugs
12.2.1.1. Porphyrin Derivatives
12.2.1.1.1. Hematoporphyrin Derivative
12.2.1.1.2. Benzoporphyrin Derivative
12.2.1.1.3. Texaphyrins
12.2.1.1.4. Others
12.2.1.2. Aminolevulic acid
12.2.1.3. Chlorines
12.2.1.4. Others
12.2.2. Devices
12.2.2.1. Disposable Fiber Optic Light Delivery Devices
12.2.2.2. Diode Laser
12.2.2.3. Lamp
12.3. Market Value Forecast By Mode of Administration, 2017 - 2031
12.3.1. Intravenous
12.3.2. Oral
12.3.3. Topical
12.4. Market Value Forecast By Application, 2017 - 2031
12.4.1. Cancer
12.4.1.1. Basal Cell Carcinoma
12.4.1.2. Non-Small Cell Lung Cancer
12.4.1.3. Head & Neck Cancer
12.4.1.4. Others
12.4.2. Dermatological Conditions
12.4.2.1. Psoriasis
12.4.2.2. Acne
12.4.2.3. Actinic Keratosis
12.4.3. Ophthalmology
12.4.3.1. Age-Related Macular Degeneration
12.4.3.2. Retinal Disease
12.4.4. Gastroenterology
12.4.5. Gynecology
12.4.6. Infectious Diseases
12.4.7. Others
12.5. Market Value Forecast By End-user, 2017 - 2031
12.5.1. Hospitals
12.5.2. Cosmetics & Dermatology Clinics
12.5.3. Cancer Treatment Centers
12.5.4. Others
12.6. Market Value Forecast By Country, 2017 - 2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Mode of Administration
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country
13. Asia Pacific Photodynamic Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2017 - 2031
13.2.1. Photosensitizer Drugs
13.2.1.1. Porphyrin Derivatives
13.2.1.1.1. Hematoporphyrin Derivative
13.2.1.1.2. Benzoporphyrin Derivative
13.2.1.1.3. Texaphyrins
13.2.1.1.4. Others
13.2.1.2. Aminolevulic acid
13.2.1.3. Chlorines
13.2.1.4. Others
13.2.2. Devices
13.2.2.1. Disposable Fiber Optic Light Delivery Devices
13.2.2.2. Diode Laser
13.2.2.3. Lamp
13.3. Market Value Forecast By Mode of Administration, 2017 - 2031
13.3.1. Intravenous
13.3.2. Oral
13.3.3. Topical
13.4. Market Value Forecast By Application, 2017 - 2031
13.4.1. Cancer
13.4.1.1. Basal Cell Carcinoma
13.4.1.2. Non-Small Cell Lung Cancer
13.4.1.3. Head & Neck Cancer
13.4.1.4. Others
13.4.2. Dermatological Conditions
13.4.2.1. Psoriasis
13.4.2.2. Acne
13.4.2.3. Actinic Keratosis
13.4.3. Ophthalmology
13.4.3.1. Age-Related Macular Degeneration
13.4.3.2. Retinal Disease
13.4.4. Gastroenterology
13.4.5. Gynecology
13.4.6. Infectious Diseases
13.4.7. Others
13.5. Market Value Forecast By End-user, 2017 - 2031
13.5.1. Hospitals
13.5.2. Cosmetics & Dermatology Clinics
13.5.3. Cancer Treatment Centers
13.5.4. Others
13.6. Market Value Forecast By Country, 2017 - 2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Mode of Administration
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country
14. Latin America Photodynamic Therapy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product Type, 2017 - 2031
14.2.1. Photosensitizer Drugs
14.2.1.1. Porphyrin Derivatives
14.2.1.1.1. Hematoporphyrin Derivative
14.2.1.1.2. Benzoporphyrin Derivative
14.2.1.1.3. Texaphyrins
14.2.1.1.4. Others
14.2.1.2. Aminolevulic acid
14.2.1.3. Chlorines
14.2.1.4. Others
14.2.2. Devices
14.2.2.1. Disposable Fiber Optic Light Delivery Devices
14.2.2.2. Diode Laser
14.2.2.3. Lamp
14.3. Market Value Forecast By Mode of Administration, 2017 - 2031
14.3.1. Intravenous
14.3.2. Oral
14.3.3. Topical
14.4. Market Value Forecast By Application, 2017 - 2031
14.4.1. Cancer
14.4.1.1. Basal Cell Carcinoma
14.4.1.2. Non-Small Cell Lung Cancer
14.4.1.3. Head & Neck Cancer
14.4.1.4. Others
14.4.2. Dermatological Conditions
14.4.2.1. Psoriasis
14.4.2.2. Acne
14.4.2.3. Actinic Keratosis
14.4.3. Ophthalmology
14.4.3.1. Age-Related Macular Degeneration
14.4.3.2. Retinal Disease
14.4.4. Gastroenterology
14.4.5. Gynecology
14.4.6. Infectious Diseases
14.4.7. Others
14.5. Market Value Forecast By End-user, 2017 - 2031
14.5.1. Hospitals
14.5.2. Cosmetics & Dermatology Clinics
14.5.3. Cancer Treatment Centers
14.5.4. Others
14.6. Market Value Forecast By Country, 2017 - 2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Mode of Administration
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product Type, 2017 - 2031
15.2.1. Photosensitizer Drugs
15.2.1.1. Porphyrin Derivatives
15.2.1.1.1. Hematoporphyrin Derivative
15.2.1.1.2. Benzoporphyrin Derivative
15.2.1.1.3. Texaphyrins
15.2.1.1.4. Others
15.2.1.2. Aminolevulic acid
15.2.1.3. Chlorines
15.2.1.4. Others
15.2.2. Devices
15.2.2.1. Disposable Fiber Optic Light Delivery Devices
15.2.2.2. Diode Laser
15.2.2.3. Lamp
15.3. Market Value Forecast By Mode of Administration, 2017 - 2031
15.3.1. Intravenous
15.3.2. Oral
15.3.3. Topical
15.4. Market Value Forecast By Application, 2017 - 2031
15.4.1. Cancer
15.4.1.1. Basal Cell Carcinoma
15.4.1.2. Non-Small Cell Lung Cancer
15.4.1.3. Head & Neck Cancer
15.4.1.4. Others
15.4.2. Dermatological Conditions
15.4.2.1. Psoriasis
15.4.2.2. Acne
15.4.2.3. Actinic Keratosis
15.4.3. Ophthalmology
15.4.3.1. Age-Related Macular Degeneration
15.4.3.2. Retinal Disease
15.4.4. Gastroenterology
15.4.5. Gynecology
15.4.6. Infectious Diseases
15.4.7. Others
15.5. Market Value Forecast By End-user, 2017 - 2031
15.5.1. Hospitals
15.5.2. Cosmetics & Dermatology Clinics
15.5.3. Cancer Treatment Centers
15.5.4. Others
15.6. Market Value Forecast By Country, 2017 - 2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Mode of Administration
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country
16. Competition Landscape
16.1. Global Sanitization Robots Market, Company Share Analysis (2022)
16.2. Company Profiles
16.2.1. GALDERMA
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Product Portfolio
16.2.1.3. Financial Overview
16.2.1.4. SWOT Analysis
16.2.1.5. Strategic Overview
16.2.2. Biofrontera AG
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. Financial Overview
16.2.2.4. SWOT Analysis
16.2.2.5. Strategic Overview
16.2.3. Sun Pharmaceuticals Industries Ltd.
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Product Portfolio
16.2.3.3. Financial Overview
16.2.3.4. SWOT Analysis
16.2.3.5. Strategic Overview
16.2.4. LUMIBIRD Groups (Quantel Medical)
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Product Portfolio
16.2.4.3. Financial Overview
16.2.4.4. SWOT Analysis
16.2.4.5. Strategic Overview
16.2.5. Modulight Corporation
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. Financial Overview
16.2.5.4. SWOT Analysis
16.2.5.5. Strategic Overview
16.2.6. Quest PharmaTech, Inc.
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Product Portfolio
16.2.6.3. Financial Overview
16.2.6.4. SWOT Analysis
16.2.6.5. Strategic Overview
16.2.7. Theralase Technologies Inc.
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. Financial Overview
16.2.7.4. SWOT Analysis
16.2.7.5. Strategic Overview
16.2.8. SUS Advancing Tecchnology CO., Ltd.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Product Portfolio
16.2.8.3. Financial Overview
16.2.8.4. SWOT Analysis
16.2.8.5. Strategic Overview
16.2.9. Others
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. Financial Overview
16.2.9.4. SWOT Analysis
16.2.9.5. Strategic Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us